Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sionna Therapeutics (SION) Retained Earnings (2024 - 2026)

Quarterly results put Retained Earnings at -$283.1 million for Q1 2026, down 43.27% from a year ago — trailing twelve months through Mar 2026 was -$283.1 million (down 43.27% YoY), and the annual figure for FY2025 was -$256.4 million, down 41.56%.

Sionna Therapeutics has reported Retained Earnings over the past 3 years, most recently at -$283.1 million for Q1 2026.

  • Retained Earnings reached -$283.1 million in Q1 2026 per SION's latest filing, down from -$256.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$181.1 million in Q4 2024 and bottomed at -$283.1 million in Q1 2026.
  • Median Retained Earnings over the past 3 years was -$225.8 million (2025), compared with a mean of -$228.3 million.
  • The largest annual shift saw Retained Earnings plummeted 41.56% in 2025 before it tumbled 43.27% in 2026.
  • Over 3 years, Retained Earnings stood at -$181.1 million in 2024, then tumbled by 41.56% to -$256.4 million in 2025, then dropped by 10.43% to -$283.1 million in 2026.
  • Business Quant data shows Retained Earnings for SION at -$283.1 million in Q1 2026, -$256.4 million in Q4 2025, and -$235.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -211.85 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -153.89 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.00 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -438.66 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -279.00 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 14.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 36.42 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 130.89 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -24.89 Mn
10 Sionna Therapeutics 1.87 Bn 1.87 Bn - -283.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -283.10 Mn
Dec 31, 2025 -256.35 Mn
Sep 30, 2025 -235.90 Mn
Jun 30, 2025 -215.64 Mn
Mar 31, 2025 -197.60 Mn
Dec 31, 2024 -181.09 Mn